UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046426
Receipt number R000052844
Scientific Title Neurological evaluation of the effects of noninvasive brain stimulation on brain rhythms and brain plasticity in the pathological brain
Date of disclosure of the study information 2021/12/21
Last modified on 2022/09/16 17:32:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Neurological evaluation of the effects of noninvasive brain stimulation on brain rhythms and brain plasticity in the pathological brain

Acronym

Neurological Effects of Noninvasive Brain Stimulation

Scientific Title

Neurological evaluation of the effects of noninvasive brain stimulation on brain rhythms and brain plasticity in the pathological brain

Scientific Title:Acronym

Neurological Effects of Noninvasive Brain Stimulation

Region

Japan


Condition

Condition

cerebral neurological disease

Classification by specialty

Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Before and during the intervention by transcranial electrical stimulation, transcranial static magnetic field stimulation, or a combination of the two, neuroscientific tests (evoked potentials by transcranial magnetic stimulation or peripheral nerve stimulation, electroencephalography, electromyography, imaging tests, etc.), physiological tests (electrocardiography, blood pressure and respiration tests, etc.), motor function assessment, memory assessment, cognitive function assessment, and behavioral assessment will be performed. The effects of peripheral nerve stimulation on brain rhythms and brain plasticity will be examined by comparing the effects in normal healthy subjects and patients with neurological diseases.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Intervention 1: Neuroscientific testing, physiological testing, and assessment of upper and lower extremity function, swallowing, memory, cognition, and behavior will be performed before and during transcranial electrical stimulation (20-30 minutes).
Intervention 2: Neuroscientific testing, physiology, upper and lower extremity function, swallowing, memory, cognition, and behavior will be assessed before and during a combination of transcranial electrical stimulation (10-30 minutes) and transcranial static magnetic field stimulation (10-30 minutes).

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Neuroscience, physiology, upper and lower extremity function, swallowing, memory, cognition, and behavioral assessments are combined with rehabilitation therapy including neuro-feedback of motor tasks, cognitive tasks, and brain activity before and during transcranial electrical stimulation (20-30 minutes) intervention.

Interventions/Control_2

Neuroscience, physiology, upper and lower limb function, swallowing, memory, cognition, and behavior are assessed before, during, and between interventions using a combination of transcranial electrical stimulation (10-30 minutes) and transcranial static magnetic field stimulation (10-30 minutes), including motor tasks, cognitive tasks, and neuro feedback of brain activity during stimulation. Rehabilitation therapy is used in combination.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Good general health.

Key exclusion criteria

Pregnant women
Dialysis patients
Metal in the cranium
Has a cardiac pacemaker
Has a spinal cord stimulator or other device
History of convulsive seizures in the past year

Target sample size

360


Research contact person

Name of lead principal investigator

1st name Sachimori
Middle name
Last name Ichimura

Organization

Murata hospital

Division name

Department of rehabilitation

Zip code

544-0011

Address

4-2-1 Tajima Ikuno-ku, Osaka-shi, Osaka-fu 544-0011 Japan

TEL

06-6757-0011

Email

r.shimomura.1988@gmail.com


Public contact

Name of contact person

1st name Ryota
Middle name
Last name Shimomura

Organization

Murata hospital

Division name

Department of rehabilitation

Zip code

544-0011

Address

4-2-1 Tajima Ikuno-ku, Osaka-shi, Osaka-fu 544-0011 Japan

TEL

06-6757-0011

Homepage URL


Email

r.shimomura.1988@gmail.com


Sponsor or person

Institute

Clinical Research Ethics Committee, Murata Hospital, Suisho-kai Medical Corporation

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Ethics Committee, Murata Hospital, Suisho-kai Medical Corporation

Address

4-2-1 Tajima Ikuno-ku, Osaka-shi, Osaka-fu 544-0011 Japan

Tel

06-6757-0011

Email

reha@muratahospital.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2020-002

Org. issuing International ID_1

Clinical Research Ethics Committee, Murata Hospital, Suisho-kai Medical Corporation

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 10 Month 26 Day

Date of IRB

2020 Year 10 Month 26 Day

Anticipated trial start date

2021 Year 12 Month 14 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 12 Month 21 Day

Last modified on

2022 Year 09 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052844